Scalper1 News
Generic drugmaker Lannett Co. (LCI) issued preliminary fiscal Q2 earnings Monday that beat expectations, sending its stock up. Lannett said sales for the quarter were about $115 million, nearly double the year-earlier number and well above analysts’ consensus of $97.5 million, according to Thomson Reuters. It expects per-share earnings of $1.18-$1.21, up from 46 cents the prior year and beating analysts’ 92 cents. The company is scheduled to Scalper1 News
Scalper1 News